Atrium ADVANTA VXT Vascular Graft, Part No. 22059, UDI 00650862220599 - Product Usage: intended f...

FDA Device Recall #Z-2589-2021 — Class II — August 25, 2021

Recall Summary

Recall Number Z-2589-2021
Classification Class II — Moderate risk
Date Initiated August 25, 2021
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Atrium Medical Corporation
Location Merrimack, NH
Product Type Devices
Quantity 28 units

Product Description

Atrium ADVANTA VXT Vascular Graft, Part No. 22059, UDI 00650862220599 - Product Usage: intended for use in arterial vascular reconstruction, segmental bypass, and for arteriovenous vascular access.

Reason for Recall

The product package may potentially contain a mismatched graft that does not contain the radial support ring (helix) identified in the labeling.

Distribution Pattern

Worldwide distribution - US Nationwide distribution in the state of Florida and the countries of South Korea and Poland.

Lot / Code Information

Lot 458755 Serial numbers 458755001 458755007 458755013 458755019 458755025 458755002 458755008 458755014 458755020 458755026 458755003 458755009 458755015 458755021 458755027 458755004 458755010 458755016 458755022 458755028 458755005 458755011 458755017 458755023 458755029 458755006 458755012 458755018 458755024 458755030

Other Recalls from Atrium Medical Corporation

Recall # Classification Product Date
Z-0024-2025 Class II iCast Covered Stent, 6MMx16MMx120CM, Model Numb... Sep 9, 2024
Z-1960-2024 Class II ADVANTA VXT, 7X70, 1GDS, NH, STR-SW. Single-End... May 3, 2024
Z-1951-2024 Class II ADVANTA VXT, 5X40, 1GDS, NH, STR-SW. Single-End... May 3, 2024
Z-1989-2024 Class II ADVANTA VXT, 6X80, 1GDS, FH, STR-TW. Single-End... May 3, 2024
Z-1954-2024 Class II ADVANTA VXT, 5X50, 1GDS, NH, STR-SW. Single-End... May 3, 2024

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.